Net Cash Provided by (Used in) Operating Activities |
48.8M |
USD |
+39% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
231M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-123M |
USD |
-14966% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
142M |
shares |
+43% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
157M |
USD |
+952% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
451M |
USD |
+1507% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
3.77M |
USD |
-43.5% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
13.6M |
USD |
+0.8% |
Mar 31, 2022 |
Q1 2022 |
Share-based Payment Arrangement, Expense |
6.34M |
USD |
+22.5% |
Mar 31, 2024 |
Q1 2024 |
Interest Expense |
39.3M |
USD |
+15.2% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |